One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for weight loss, and major food conglomerates are trying to cater to their ...
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.
Enhancing its peptide synthesis capabilities to meet increasing demand from its global partners for efficient and scalable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback